Sharon Muentener

Sharon Muentener has extensive work experience in financial planning and analysis roles. Sharon is currently the Vice President of FP&A at Generate Biomedicines, Inc. since March 2022. Prior to that, they worked as an Executive Director of FP&A at CRISPR Therapeutics from November 2019 to February 2022. Sharon also held various roles at Moderna, including Senior Director of Financial Planning and Analysis and Director of Financial Planning and Analysis - Ventures, from August 2016 to November 2019. Before that, they served as an Associate Director of Strategic Corporate Finance at Biogen Idec from July 2013 to August 2016. Sharon Muentener began their career as an Equity Research Associate at Fidelity Investments from 2004 to 2007. Sharon also has experience as an Expert and Specialist at McKinsey & Company from 2009 to 2013.

Sharon Muentener completed their Master of Business Administration (MBA) from Harvard Business School between 2007 and 2009. Sharon also holds a Bachelor of Science (B.S.) degree in Accounting and Finance from Georgetown University, which they earned from 2000 to 2004.